Michael H. Carrel, President, CEO, & Director at AtriCure, Inc. (ATRC), sold 75,000 shares at $64.00 ($4.8M) on 2021-02-11, disclosed to the SEC on 2021-02-12.
Open-market sale of $4.8M ATRC by President, CEO, & Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.00 | 25,000 | $1.6M | 32.8% |
| 2 | $64.00 | 25,000 | $1.6M | 33.3% |
| 3 | $65.00 | 25,000 | $1.6M | 33.9% |
| Total | $64.00 avg | 75,000 | $4.8M | 100% |
| Filing → |
| ATRC | SELL | 2021-01-13 | $1.5M | — | Filing → |
| ATRC | SELL | 2020-12-28 | $1.4M | — | Filing → |
| ATRC | SELL | 2020-12-23 | $4.2M | — | Filing → |